RUDÁ, Jana, Petra AMCHOVÁ, Alena MÁCHALOVÁ, Jana PISTOVČÁKOVÁ and Alexandra ŠULCOVÁ. PRENATAL EXPOSURE TO MODAFINIL ALTERS LOCOMOTOR BEHAVIOUR AND LEUCOCYTE PHAGOCYTOSIS IN MICE. Psychiatria danubina. Zagreb: Medicinska naklada Zagreb, 2018, vol. 30, No 3, p. 356-366. ISSN 0353-5053. Available from: https://dx.doi.org/10.24869/psyd.2018.356.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name PRENATAL EXPOSURE TO MODAFINIL ALTERS LOCOMOTOR BEHAVIOUR AND LEUCOCYTE PHAGOCYTOSIS IN MICE
Name in Czech Prenatální expozice modafinilu ovlivňuje lokomoci a leukocytární fagocytózu u myších samců
Authors RUDÁ, Jana (203 Czech Republic, guarantor, belonging to the institution), Petra AMCHOVÁ (203 Czech Republic, belonging to the institution), Alena MÁCHALOVÁ (203 Czech Republic, belonging to the institution), Jana PISTOVČÁKOVÁ (203 Czech Republic, belonging to the institution) and Alexandra ŠULCOVÁ (203 Czech Republic, belonging to the institution).
Edition Psychiatria danubina, Zagreb, Medicinska naklada Zagreb, 2018, 0353-5053.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher Croatia
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 0.683
RIV identification code RIV/00216224:14110/18:00103872
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.24869/psyd.2018.356
UT WoS 000445798700014
Keywords in English modafinil; prenatal administration; locomotion; phagocytosis; mice
Tags 14110516, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 26/3/2019 10:45.
Abstract
Background: Modafinil is a psychostimulant drug prescribed mainly for treatment of narcolepsy but is used as a "smart drug" by wide populations to increase wakefulness, concentration and overall mental performance. The aim of this study was to assess potential developmental toxicity of modafinil. Materials and methods: Pregnant female mice were given either saline or modafinil (50 mg/kg orally) from gestational day (GD) 3 to GD 10 and then a challenge dose on the GD 17. The male offspring were treated analogously at the age of 10 weeks. Changes in the spontaneous locomotor/exploratory behaviour and anxiogenic profile in the open-field test were assessed in naive animals, after an acute and 8th modafinil dose and the challenge dose following a 7-day wash-out period. One month after completion of the behavioural study, the leukocyte phagocytosis was examined by zymosan induced and luminol-aided chemiluminiscence assay in vitro. Results: The most important finding of this study was the immunosuppressing effect on leukocyte activity, hypolocomotion and increased behavioural response to modafinil-induced psychostimulation caused by prenatal exposure to the same drug. We did not detect significantly altered anxiety-related behaviour in any group disregarding the pre- and postnatal treatments. Conclusion: This is the first evidence of developmental toxicity of modafinil which needs to be taken into account as a potential risk factor when modafinil is administered to women who may become or are pregnant.
Links
MUNI/A/1132/2017, interní kód MUName: Behaviorální psychofarmakologie a farmakokinetika v preklinickém výzkumu léčiv
Investor: Masaryk University, Category A
PrintDisplayed: 28/4/2024 09:11